CADL Financials

Candel Therapeutics Inc - Financial statements & key metrics

Stock Price

$12.85

Market Cap

$592.02M

P/E Ratio

-19.8

EPS

$-0.56

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-55.18M

EPS (Diluted)

$-1.74

Balance Sheet Highlights

Total Assets

$106.87M

Total Liabilities

$40.54M

Shareholders Equity

-

Cash & Equivalents

$102.65M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-27.02M

CapEx

-

Free Cash Flow

-

Profitability Metrics

00

ROE

-70.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CADL revenue?

View CADL's income statement for detailed revenue data.

Is CADL profitable?

CADL reported a loss of $55.18M in the most recent quarter.

What is CADL market cap?

CADL has a market capitalization of $592.02M, making it a small-cap stock.

Does CADL have debt?

View CADL's balance sheet for debt information.

What is CADL cash flow?

Cash flow data is available in the full financial statements.

Explore Categories